Human stem cell-derived cardiac spheroids as 3D in vitro model for cardiotoxicity testing

被引：0
|
作者：
Kim, Ki-Suk [1 ]
机构：
[1] Korea Inst Toxicol, Daejeon, South Korea
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2020年 / 105卷
关键词：
D O I：
10.1016/j.vascn.2020.106848
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
155
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Development and characterization of a human embryonic stern cell-derived 3D neural tissue model for neurotoxicity testing
    Sandstrom, J.
    Eggermann, E.
    Charvet, I
    Roux, A.
    Toni, N.
    Greggio, C.
    Broyer, A.
    Monnet-Tschudi, F.
    Stoppini, L.
    [J]. TOXICOLOGY IN VITRO, 2017, 38 : 124 - 135
  • [32] An in vitro Model of Cardiac Stem Cell Therapy to Study the Coupling of Primary and Stem Cell-derived Cardiomyocytes
    Pasqualini, Francesco S.
    Aratyn-Schaus, Yvonne
    Yuan, Hongyan
    McCain, Megan L.
    Ye, George J.
    Sheehy, Sean P.
    Campbell, Patrick H.
    Parker, Kevin K.
    [J]. CIRCULATION RESEARCH, 2015, 117
  • [33] Human pluripotent stem cell-derived endothelial cells are vasoactive in vitro and capable of engineering 3D vascular grafts
    Husveth-Toth, M.
    Gara, E.
    Nemes, A.
    Molnar, A. A.
    Csepi, K.
    Radovits, T.
    Harding, S. E.
    Merkely, B.
    Foldes, G.
    [J]. CARDIOVASCULAR RESEARCH, 2018, 114 : S111 - S111
  • [34] Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing
    Gintant, Gary
    Burridge, Paul
    Gepstein, Lior
    Harding, Sian
    Herron, Todd
    Hong, Charles
    Jalife, Jose
    Wu, Joseph C.
    [J]. CIRCULATION RESEARCH, 2019, 125 (10) : E75 - E92
  • [35] Induced Pluripotent Stem Cell-derived Cardiac Myocytes To Assess Anthracycline Cardiotoxicity
    Jacobs, Johanna E.
    Duelen, Robin
    Gillijns, Hilde
    Johar, Angad
    Heggermont, Ward
    Sampaolesi, Maurilio
    Segers, Heidi
    Herrmann, Joerg
    Van Aelst, Lucas
    Janssens, Stefan P.
    [J]. CIRCULATION RESEARCH, 2023, 133
  • [36] Induced pluripotent stem cell-derived cardiac myocytes to assess anthracycline cardiotoxicity
    Jacobs, J.
    Duelen, R.
    Gillijns, H.
    Johar, A. S.
    Heggermont, W.
    Sampaolesi, M.
    Segers, H.
    Herrmann, J.
    Janssens, S.
    Van Aelst, L.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [37] In vitro assessments of drug-induced delayed cardiotoxicity using human stem cell-derived cardiomyocytes
    Lu, Hua Rong
    Vlaminckx, Eddy
    Geysken, Danny
    Carrasqueiro, Gabriela T.
    Kreir, Mohamed
    Teisman, Ard
    Gallacher, David J.
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [38] In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
    Tanaka, Tomofumi
    Tohyama, Shugo
    Murata, Mitsushige
    Nomura, Fumimasa
    Kaneko, Tomoyuki
    Chen, Hao
    Hattori, Fumiyuki
    Egashira, Toru
    Seki, Tomohisa
    Ohno, Yohei
    Koshimizu, Uichi
    Yuasa, Shinsuke
    Ogawa, Satoshi
    Yamanaka, Shinya
    Yasuda, Kenji
    Fukuda, Keiichi
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (04) : 497 - 502
  • [39] Current status and future perspectives of toxicity testing using stem cell-derived 3D models
    Kanda, Y.
    [J]. TOXICOLOGY LETTERS, 2022, 368 : S17 - S18
  • [40] Disease Modeling in Stem Cell-Derived 3D Organoid Systems
    Dutta, Devanjali
    Heo, Inha
    Clevers, Hans
    [J]. TRENDS IN MOLECULAR MEDICINE, 2017, 23 (05) : 393 - 410
12345